These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Going over the patent cliff. Schommer JC Minn Med; 2011 Oct; 94(10):42-3. PubMed ID: 23256283 [No Abstract] [Full Text] [Related]
3. Prescription-drug coupons--no such thing as a free lunch. Ross JS; Kesselheim AS N Engl J Med; 2013 Sep; 369(13):1188-9. PubMed ID: 23984672 [No Abstract] [Full Text] [Related]
4. Effect of generic drug competition on the price of prescription drugs in Ontario. Lexchin J CMAJ; 1993 Jan; 148(1):35-8. PubMed ID: 8439888 [TBL] [Abstract][Full Text] [Related]
5. Encouraging generic use can yield significant savings. Zimmerman C Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854 [TBL] [Abstract][Full Text] [Related]
6. Don't pay too much for generic fills. Pass-through pricing is a good way for a payer to realize the benefit of increased prescribing of generic drugs. Cahn LJ Manag Care; 2010 Nov; 19(11):21-7. PubMed ID: 21141372 [No Abstract] [Full Text] [Related]
7. Drug coupons don't always save money. Consum Rep; 2009 Feb; 74(2):13. PubMed ID: 19306503 [No Abstract] [Full Text] [Related]
9. Prescription drug prices in Canada. Gross D Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123 [No Abstract] [Full Text] [Related]
10. Impact of cost sharing on prescription drugs used by Medicare beneficiaries. Goedken AM; Urmie JM; Farris KB; Doucette WR Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109 [TBL] [Abstract][Full Text] [Related]
11. Zero copayment for generic statins could save billions. Manag Care; 2013 Mar; 22(3):44. PubMed ID: 23610806 [No Abstract] [Full Text] [Related]
12. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices. Sarpatwari A; Avorn J; Kesselheim AS JAMA; 2018 Jun; 319(23):2373-2374. PubMed ID: 29800027 [No Abstract] [Full Text] [Related]
13. Pharmac dogma. Douglas B N Z Med J; 2007 Feb; 120(1249):U2430. PubMed ID: 17308566 [No Abstract] [Full Text] [Related]
15. Prescription drugs and health care reform. Gibaldi M Pharmacotherapy; 1993; 13(6):583-9. PubMed ID: 8302681 [No Abstract] [Full Text] [Related]
16. How to Reduce Prescription Drug Prices: First, Do No Harm. Atlas S Mo Med; 2020; 117(1):14-15. PubMed ID: 32158034 [No Abstract] [Full Text] [Related]
17. Generics industry and doctors nervous over free trade deal. Burton B BMJ; 2004 May; 328(7449):1158. PubMed ID: 15142916 [No Abstract] [Full Text] [Related]
19. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs. Gudiksen KL; King JS J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534 [No Abstract] [Full Text] [Related]
20. Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending. Kesselheim AS; Fischer MA; Avorn J Health Aff (Millwood); 2006; 25(6):1637-47. PubMed ID: 17102189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]